The Trendlines Group
About
Innovation commercialization company founded in 1993, inventing and investing in medical and agricultural technologies. Trades on Singapore Stock Exchange (SGX: 42T). Hands-on investor involved in all aspects of portfolio companies from technology development to business building.
Key facts
At-a-glance profile data
- Website
- trendlines.com
- Type
- Investment Firm
- Headquarters
- Israel
- Funds raised
- $40M
- Portfolio companies
- 14
- Stages
- SeedSeries ASeries B
- Cheque size
- $800K to $20M
- Sector focus
- HealthcareDiagnosticsHeart FailureAgritechBiotech
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 16 Feb 2025 | IBI-Ag | Series A | $6M |
| 6 Jan 2025 | Arcuro Medical | Series A | Undisclosed |
| 5 Dec 2024 | Celleste Bio | Seed | $5M |
| 14 Feb 2024 | Vessi Medical | Series A | $17M |
| 5 Sept 2023 | 546735 | Series A | $8M |
| 20 Oct 2022 | Celleste Bio | Seed | Undisclosed |
| 7 Jul 2022 | Phytolon | Series A | $15M |
| 16 Dec 2021 | 77479 | Series B | $5M |
| 4 Aug 2021 | AgroScout | Series A | $8M |
| 22 Jun 2021 | Equinom | Series C | $20M |
Add first review
Frequently asked
What companies has The Trendlines Group invested in?
The Trendlines Group has invested in IBI-Ag, Arcuro Medical, Celleste Bio, Vessi Medical, 546735 and 9 more.